NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/16/2026
Back to search
Official data from USPTO
BIOSE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOSE
ST13
US500000079182715Class
5, 41, 42
Filing
79182715
Registration
5056931
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
08/16/2026
Trademark type
Word
Nice classes
5, 41, 42
Filing date
07/03/2015
Registration date
10/11/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2026
Last transaction
08/16/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Arpajon Sur Cere, FR
Examiner
NEVILLE, BRIAN
Current location
Historical data usage
Holders and representatives
Holders
BIOSE INDUSTRIE
BIOSE
Representatives
William S. Fultz Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 5Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products made with the microbiotabacteriaprobiotics and tribiotics for treating gynecological disordersintestinal disordersgastroenterological disorders linked to imbalances in the intestinal floravaginal floradermatological diseasesimmuneauto-immune and inflammatorydiseases of the earnose and throatallergies; chemical or biological pharmaceutical preparations for pharmaceuticalmedical and sanitary purposesmicrobiotabacteriaprobiotics and tribiotics for treating gynecological disordersintestinal disordersgastroenterological disorders linked to imbalances in the intestinal floravaginal floradermatological diseasesimmuneauto-immune and inflammatorydiseases of the earnose and throatallergies; sanitary and medical preparationsbacteria for use in the composition of biological pharmaceuticals for treating gynecological disordersintestinal disordersgastroenterological disorders linked to imbalances in the intestinal floravaginal floradermatological diseasesimmuneauto-immune and inflammatorydiseases of the earnose and throatallergies; biological or chemical preparations for pharmaceuticalmedical usetoiletprobioticstribiotics in capsulescapsules and sachets for treating or preventing the gastroenterological diseasegyncologicalearnose and throatdermatologicalallergicimmune or inflammatorydiseases associated with an imbalance in the vaginal or intestinal floraflatulencediarrheaabdominal painspasmsfor improving regulation of intestinal transit; vaginal capsules for treating gynecological diseases; preparations for medical useantifungalsantimycoticsantiflatulent agentsantidiarrheic agentsantispasmodicsantiinflammatories or antibiotics; disinfectants for hygiene care of patients suffering from gastroenterological diseasesimbalance of the intestinal floragynecological diseasesimbalance of the vaginal flora; nutritional supplementsfood beveragesbars and meal replacement substances adapted for medical usedietetic purposestreating or preventing gynecological disordersgastroenterologicalintestinal disorders linked to imbalances in the intestinal floravaginal floradermatological diseasesimmuneauto-immune and inflammatorydiseases of the earnose and throat; nutritional supplementsmeal replacement foodsbeveragesbars made from a combination of probioticsminerals and/or vitamins; vitamin preparationsvitamin supplements; medical preparations for slimming; mineral food supplements
Class 41
Arranging and conducting of educational colloquiumsconferencesseminars and events for scientific purposes in the field of microbiotaof probiotics as pharmaceutical preparationsof the probiotics industryof good practice in the field of microbiotaof probioticsof changes to regulations relating to probiotics and microbiota
Class 42
Laboratory services for the provision of scientific analysis and research servicesmedicalpharmaceuticalpharmacologicalbacteriologicalchemical and microbiologicaldesign and production of pharmaceutical preparationsprobioticstribiotics for others; consulting in production of pharmaceutical preparations; quality control; testing in laboratory; services for assessing the efficiency of pharmaceuticals; auditing and auditing pharmaceutical manufacturing processes; packaging design services; kitchen design of preventive quality assurance and quality control relating to the manufacture of pharmaceutical preparations; auditing and testing standards and practices in the field of the manufacture of probioticstribioticsensure compliance with governmental regulations and industrial practicespractices quality control and quality assurance; conducting pharmaceutical research projects and technical project studies; engineering; provision of information and data relating to medical and scientific research in the field of pharmaceuticalsprobioticsclinical trials relating to scientific research and development; provision and exchange of knowledgeindustrial know-how and data relating to scientific research and development; provision and exchange of information and data exchange between scientistsmanufacturers and health authorities relating to pharmaceutical regulatory affairs and the application thereof to probiotics; expertise services and technical advice in the field of scientific research for medical and pharmaceutical purposesin the field of probiotics; development and maintenance of data banks and databases; extraction and retrieval of information and data mining; managing of working groups bringing together scientists and manufacturers to resolve problems in connection with probiotics; research and drafting of information provided by scientific research in the field of medical researchpharmaceuticalpharmacological in regulatory affairs in the field of probiotics
Publications
History of USPTO decisions and trademark events.
42 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
08/16/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/10/2026
ES71
TEAS SECTION 71 RECEIVED
05/05/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/22/2026
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
10/11/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
07/24/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/31/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/23/2023
INPC
INVALIDATION PROCESSED
09/23/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/13/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/13/2023
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
01/13/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/10/2023
ES71
TEAS SECTION 71 RECEIVED
07/01/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
09/11/2020
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
03/13/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/03/2017
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
02/17/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/13/2017
FIMP
FINAL DISPOSITION PROCESSED
02/13/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/11/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
10/11/2016
PUBO
PUBLISHED FOR OPPOSITION
07/26/2016
NPUB
NOTICE OF PUBLICATION
07/06/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/20/2016
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/16/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/14/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2016
ALIE
ASSIGNED TO LIE
05/27/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/17/2016
RFNT
REFUSAL PROCESSED BY IB
03/26/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/04/2016
RFRR
REFUSAL PROCESSED BY MPU
03/04/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/04/2016
CNRT
NON-FINAL ACTION WRITTEN
03/03/2016
MAFR
APPLICATION FILING RECEIPT MAILED
03/01/2016
DOCK
ASSIGNED TO EXAMINER
02/25/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/25/2016
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/24/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/23/2016
Continuous trademark protection
Get notified about every new filing that threatens BIOSE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.